→ New York City has a new incubator, Alexandria LaunchLabs. The space, the plan for which was announced about one year ago, opened this week. The startup incubator awarded a $100,000 Entrepreneurship Prize to one of its 13 startups, Neochromosome, which designs and synthesizes full chromosomes rather than individual genes.
→ J&J Innovation has had a busy start to the year. In addition to leading the $900 million round for Grail and partnering closely with Protagonist, the pharma giant has racked up more than 20 alliances since the start of 2017. Outlining its new set of collaborations, J&J says it has also forged a partnership with UC San Diego on NASH research. And on the neglected diseases front, J&J is opening up its library of molecules to researchers to pick through for promising leads.
→ LabConnect, which provides central laboratory and support services to biopharmaceutical, medical device, and contract research organizations, completed Series A funding with $24.5 million from ABS Capital Partners, Pablo Capital, and BroadOak Capital.
→ Ocugen closed a $7.5 million round of Series B funding. The round was co-led by Abdi Ibrahim and the JSC Lancaster Group.
The best place to read Endpoints News? In your inbox.
Full-text daily reports for those who discover, develop, and market drugs. Join 17,000+ biopharma pros who read Endpoints News by email every day.Free Subscription